• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Intravenous Immunoglobulin for the Treatment of COVID-19: A Promising Tool.静脉注射免疫球蛋白用于治疗新型冠状病毒肺炎：一种有前景的工具。
Respiration. 2020;99(12):1087-1089. doi: 10.1159/000512727. Epub 2020 Nov 19.
2
SARS-CoV-2 infection complicated by inflammatory syndrome. Could high-dose human immunoglobulin for intravenous use (IVIG) be beneficial?新型冠状病毒2型感染并发炎症综合征。静脉注射用大剂量人免疫球蛋白（IVIG）是否有益？
Autoimmun Rev. 2020 Jul;19(7):102559. doi: 10.1016/j.autrev.2020.102559. Epub 2020 May 1.
3
Intravenous immunoglobulin as a therapeutic option for patients with worsening COVID-19 under rituximab.静脉注射免疫球蛋白作为利妥昔单抗治疗 COVID-19 恶化患者的一种选择。
BMJ Case Rep. 2021 Jun 28;14(6):e243338. doi: 10.1136/bcr-2021-243338.
4
A new diagnosis of systemic capillary leak syndrome in a patient with COVID-19.一名新冠肺炎患者被新诊断出患有全身性毛细血管渗漏综合征。
Rheumatology (Oxford). 2021 Jan 5;60(1):e19-e20. doi: 10.1093/rheumatology/keaa606.
5
Positive outcome in a patient with coronavirus disease 2019 and common variable immunodeficiency after intravenous immunoglobulin.一名2019冠状病毒病患者在接受静脉注射免疫球蛋白治疗后出现阳性结果，该患者同时患有常见变异型免疫缺陷。
Ann Allergy Asthma Immunol. 2020 Sep;125(3):349-350. doi: 10.1016/j.anai.2020.06.006. Epub 2020 Jun 4.
6
Successful treatment with plasma exchange followed by intravenous immunoglobulin in a critically ill patient with COVID-19.COVID-19 危重症患者采用血浆置换联合静脉注射免疫球蛋白治疗获得成功。
Int J Antimicrob Agents. 2020 Aug;56(2):105974. doi: 10.1016/j.ijantimicag.2020.105974. Epub 2020 Apr 13.
7
Neurological Disorders Identified during Treatment of a SARS-CoV-2 Infection.2019冠状病毒病感染治疗期间发现的神经系统疾病
Intern Med. 2020 Sep 1;59(17):2187-2189. doi: 10.2169/internalmedicine.5447-20. Epub 2020 Jul 21.
8
Anti-SARS-CoV-2 and Autoantibody Profiling of a COVID-19 Patient With Subacute Psychosis Who Remitted After Treatment With Intravenous Immunoglobulin.一名患有亚急性精神病的新冠肺炎患者经静脉注射免疫球蛋白治疗后病情缓解，其抗SARS-CoV-2及自身抗体分析
Biol Psychiatry. 2023 May 1;93(9):e25-e29. doi: 10.1016/j.biopsych.2022.09.007. Epub 2022 Dec 5.
9
SARS-CoV-2 Induces Acute and Refractory Relapse of Systemic Capillary Leak Syndrome (Clarkson's Disease).严重急性呼吸综合征冠状病毒2引发全身性毛细血管渗漏综合征（克拉克森病）的急性和难治性复发。
Am J Med. 2020 Nov;133(11):e663-e664. doi: 10.1016/j.amjmed.2020.03.057. Epub 2020 May 13.
10
Symptoms and immunoglobulin development in hospital staff exposed to a SARS-CoV-2 outbreak.接触 SARS-CoV-2 疫情的医院工作人员的症状和免疫球蛋白发展情况。
Pediatr Allergy Immunol. 2020 Oct;31(7):841-847. doi: 10.1111/pai.13278. Epub 2020 Jun 18.

引用本文的文献

1
Intravenous immunoglobulin therapy: usage patterns and response to treatment in Qatar over ten years.静脉注射免疫球蛋白疗法：卡塔尔十年间的使用模式及治疗反应
Front Immunol. 2024 Dec 2;15:1481079. doi: 10.3389/fimmu.2024.1481079. eCollection 2024.
2
Evaluation of the Efficacy and Safety of Intravenous Immunoglobulin (IVIG) in Moderate-to-Severe Hospitalized COVID-19 Patients: A Randomized, Open-Label Parallel-Group Study.静脉注射免疫球蛋白（IVIG）治疗中重度住院COVID-19患者的疗效和安全性评估：一项随机、开放标签平行组研究。
Can J Infect Dis Med Microbiol. 2024 May 21;2024:7209380. doi: 10.1155/2024/7209380. eCollection 2024.
3
Complex changes in serum protein levels in COVID-19 convalescents.新型冠状病毒肺炎恢复期患者血清蛋白水平的复杂变化。
Sci Rep. 2024 Feb 23;14(1):4479. doi: 10.1038/s41598-024-54534-7.
4
Investigation of cardiac adverse effects in COVID-19 ARDS patients treated with intravenous immunoglobulin.对接受静脉注射免疫球蛋白治疗的新冠病毒感染相关性急性呼吸窘迫综合征（COVID-19 ARDS）患者心脏不良反应的调查。
North Clin Istanb. 2023 Aug 26;10(5):560-566. doi: 10.14744/nci.2023.50336. eCollection 2023.
5
A Molecular Biomarker-Based Triage Approach for Targeted Treatment of Post-COVID-19 Syndrome Patients with Persistent Neurological or Neuropsychiatric Symptoms.基于分子生物标志物的分诊方法，用于治疗 COVID-19 后综合征患者持续存在的神经或神经精神症状的靶向治疗。
Adv Exp Med Biol. 2023;1412:97-115. doi: 10.1007/978-3-031-28012-2_5.
6
COVID-19-specific transcriptomic signature detectable in blood across multiple cohorts.在多个队列的血液中可检测到新冠病毒（COVID-19）特异性转录组特征。
Front Genet. 2022 Aug 5;13:929887. doi: 10.3389/fgene.2022.929887. eCollection 2022.
7
Successful Immunomodulatory Treatment of COVID-19 in a Patient With Severe ACTH-Dependent Cushing's Syndrome: A Case Report and Review of Literature.COVID-19 成功的免疫调节治疗：一例严重 ACTH 依赖性库欣综合征患者的病例报告及文献复习。
Front Endocrinol (Lausanne). 2022 Jun 22;13:889928. doi: 10.3389/fendo.2022.889928. eCollection 2022.
8
Passive Immunotherapy Against SARS-CoV-2: From Plasma-Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants.针对 SARS-CoV-2 的被动免疫疗法：从基于血浆的疗法到单一强效抗体，以在与变异体的竞赛中保持领先地位。
BioDrugs. 2022 May;36(3):231-323. doi: 10.1007/s40259-022-00529-7. Epub 2022 Apr 27.
9
Post covid pneumonia pulmonary fibrosis and encephalitis in a term neonate with prenatal exposure to SARS CoV-2: A case report.一名足月新生儿产前暴露于新冠病毒后出现新冠肺炎、肺纤维化和脑炎：病例报告
IDCases. 2022;27:e01414. doi: 10.1016/j.idcr.2022.e01414. Epub 2022 Jan 22.
10
Pathogenesis and treatment of cytokine storm in COVID-19.新型冠状病毒肺炎细胞因子风暴的发病机制与治疗
Turk J Biol. 2021 Aug 30;45(4):372-389. doi: 10.3906/biy-2105-37. eCollection 2021.

Intravenous Immunoglobulin for the Treatment of COVID-19: A Promising Tool.

作者信息

Tzilas Vasilios, Manali Effrosyni, Papiris Spyridon, Bouros Demosthenes

机构信息

First Academic Department of Pneumonology, Interstitial Lung Diseases Unit, Hospital for Diseases of the Chest, "Sotiria," Medical School, National and Kapodistrian University of Athens, Athens, Greece.

Athens Medical Center, Athens, Greece.

出版信息

Respiration. 2020;99(12):1087-1089. doi: 10.1159/000512727. Epub 2020 Nov 19.

DOI:10.1159/000512727
PMID:33212437
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7801989/
Abstract
摘要